EDIT vs META · rev $32.3M vs P/E 29, rev $200.97B
Editas Medicine Inc (EDIT) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
EDIT currently screens at market cap $375.2M. META currently screens at market cap $1.64T and trailing P/E 28.8.
Not investment advice. Open the EDIT and META stock pages for the full models.
Not investment advice.